search
Back to results

STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure (STARBRITE)

Primary Purpose

Congestive Heart Failure

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Brain Natriuretic Peptide Levels -- Diagnostic testing
clinical assessment
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Congestive Heart Failure focused on measuring heart failure, brain natriuretic peptide

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients admitted with NYHA class III/IV symptoms of heart failure
  2. Left ventricular ejection fraction ≤35%
  3. Will have received at least one dose of intravenous diuretics during the current hospitalization
  4. Prior to discharge, has received heart failure education and has learned about daily weights, and fluid, sodium, and dietary restrictions
  5. Able to return for follow-up care at the Brigham and Women's Hospital Cardiomyopathy Clinic or the Duke Heart Failure Management Program
  6. Has regular access to a telephone
  7. ≥18 years of age

Exclusion Criteria:

  1. Moderate to severe valvular stenosis
  2. Admitted with acute coronary syndrome
  3. Creatinine >3.5
  4. Renal failure on hemodialysis
  5. Pregnant or lactating

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Other

    Arm Label

    Congestion Score Strategy

    BNP Strategy

    Arm Description

    Outcomes

    Primary Outcome Measures

    Number of days neither hospitalized nor dead from the date of the first clinic visit to 90 days thereafter

    Secondary Outcome Measures

    1. Number of days not dead from the date of the first clinic visit to 90 days thereafter 2.Number of days not hospitalized from the date of the first clinic visit to 90 days thereafter

    Full Information

    First Posted
    June 7, 2007
    Last Updated
    August 20, 2014
    Sponsor
    Duke University
    Collaborators
    American Heart Association
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00484770
    Brief Title
    STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
    Acronym
    STARBRITE
    Official Title
    Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: Brain Natriuretic Peptide Levels Versus the Clinical Congestion Score
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2007
    Overall Recruitment Status
    Completed
    Study Start Date
    February 2003 (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    August 2005 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Duke University
    Collaborators
    American Heart Association

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The primary hypothesis is that, in patients with advanced heart failure, an outpatient fluid management strategy guided by BNP levels and clinical targets will lead to fewer days hospitalized or dead over a 3-month period compared to an outpatient fluid management strategy using clinical targets alone.
    Detailed Description
    STARBRITE will test the hypothesis that a defined fluid management strategy, tailored to specific symptoms and physiological targets, will improve morbidity and mortality in the advanced heart failure population. Individual targets for each patient will be based on the outcome of the index hospitalization, during which therapy is adjusted to optimize clinical status, blood pressure, and renal function. Identifying a standard fluid management strategy may be an important way to limit the complications of diuretic therapy and the duration of hospitalization for these patients. In addition, a standard approach may provide objective criteria that can be used to systematically deliver care in many types of clinical settings. In this study, patients will be randomized to two strategies of outpatient fluid management: 1) the Congestion Score Strategy and, 2) the BNP Strategy.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Congestive Heart Failure
    Keywords
    heart failure, brain natriuretic peptide

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Parallel Assignment
    Masking
    Single
    Allocation
    Randomized
    Enrollment
    135 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Congestion Score Strategy
    Arm Type
    Other
    Arm Title
    BNP Strategy
    Arm Type
    Other
    Intervention Type
    Device
    Intervention Name(s)
    Brain Natriuretic Peptide Levels -- Diagnostic testing
    Intervention Type
    Other
    Intervention Name(s)
    clinical assessment
    Primary Outcome Measure Information:
    Title
    Number of days neither hospitalized nor dead from the date of the first clinic visit to 90 days thereafter
    Time Frame
    90 day follow up
    Secondary Outcome Measure Information:
    Title
    1. Number of days not dead from the date of the first clinic visit to 90 days thereafter 2.Number of days not hospitalized from the date of the first clinic visit to 90 days thereafter
    Time Frame
    90 day follow up

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients admitted with NYHA class III/IV symptoms of heart failure Left ventricular ejection fraction ≤35% Will have received at least one dose of intravenous diuretics during the current hospitalization Prior to discharge, has received heart failure education and has learned about daily weights, and fluid, sodium, and dietary restrictions Able to return for follow-up care at the Brigham and Women's Hospital Cardiomyopathy Clinic or the Duke Heart Failure Management Program Has regular access to a telephone ≥18 years of age Exclusion Criteria: Moderate to severe valvular stenosis Admitted with acute coronary syndrome Creatinine >3.5 Renal failure on hemodialysis Pregnant or lactating
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Monica R Shah, MD
    Organizational Affiliation
    Duke University Medical Center/Washington Hospital Center
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    Citation
    Shah, MR for the STARBRITE Investigators. STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients with Advanced Heart Failure. Abstract. Circulation Supplement, October 2005. Presented at the American Heart Association Meeting in November 2005.
    Results Reference
    result

    Learn more about this trial

    STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure

    We'll reach out to this number within 24 hrs